La Trobe
238273_Johnstone,C_2018.pdf (8.1 MB)

Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer

Download (8.1 MB)
journal contribution
posted on 2023-05-10, 04:50 authored by Cameron JohnstoneCameron Johnstone, Andrew D Pattison, Kylie L Gorringe, Paul F Harrison, David R Powell, Peter Lock, David Baloyan, Matthias ErnstMatthias Ernst, Alastair G Stewart, Traude H Beilharz, Robin AndersonRobin Anderson
Triple-negative breast cancer (TNBC) represents 10-20% of all human ductal adenocarcinomas and has a poor prognosis relative to other subtypes. Hence, new molecular targets for therapeutic intervention are necessary. Analyses of panels of human or mouse cancer lines derived from the same individual that differ in their cellular phenotypes but not in genetic background have been instrumental in defining the molecular players that drive the various hallmarks of cancer. To determine the molecular regulators of metastasis in TNBC, we completed a rigorous in vitro and in vivo characterisation of four populations of the MDA-MB-231 human breast cancer line ranging in aggressiveness from non-metastatic to spontaneously metastatic to lung, liver, spleen and lymph node. Single nucleotide polymorphism (SNP) array analyses and genome-wide mRNA expression profiles of tumour cells isolated from orthotopic mammary xenografts were compared between the four lines to define both cell autonomous pathways and genes associated with metastatic proclivity. Gene set enrichment analysis (GSEA) demonstrated an unexpected association between both ribosome biogenesis and mRNA metabolism and metastatic capacity. Differentially expressed genes or families of related genes were allocated to one of four categories, associated with either metastatic initiation (e.g. CTSC, ENG, BMP2), metastatic virulence (e.g. ADAMTS1, TIE1), metastatic suppression (e.g. CST1, CST2, CST4, CST6, SCNNA1, BMP4) or metastatic avirulence (e.g. CD74). Collectively, this model system based on MDA-MB-231 cells should be useful for the assessment of gene function in the metastatic cascade and also for the testing of novel experimental therapeutics for the treatment of TNBC.


This study was supported by a Cass Foundation of Victoria (Australia) Grant # SM/14/5567 (to C.N.J.) and National Health and Medical Research Council (Australia) project grants (APP1128250 and APP1042848) to T.H.B. The Australian Research Council also supported this work.


Publication Date



Disease Models and Mechanisms





Article Number





The Company of Biologists



Rights Statement

© 2018. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Usage metrics

    Journal Articles


    No categories selected